Householder Group Estate & Retirement Specialist’s Checkpoint Therapeutics CKPT Stock Holding History

Householder Group Estate & Retirement Specialist’s Portfolio CKPT Stock Details CKPT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-200	Closed	–	–	656
2024 Q3	$0	Buy	+200	New	+$462	﹤0.01%	1183
2024 Q2	–	Sell	-200	Closed	-$410	–	1217
2024 Q1	$410	Sell	200 -100	-33%	-$199	﹤0.01%	1169
2023 Q4	$0	Hold	300	–	–	﹤0.01%	1162
2023 Q3	$510	Buy	+300	New	+$682	﹤0.01%	1184
2023 Q1	$1K	Buy	+300	New	+$1.51K	﹤0.01%	1133

Other funds holding CKPT

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return

KAS

Kestra Advisory Services Austin, Texas $31B AUM 28.39% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

6CM

683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return

Householder Group Estate & Retirement Specialist's CKPT Position: Q4 2024 in Review

Householder Group Estate & Retirement Specialist sold out of Checkpoint Therapeutics (CKPT) in Q4 2024, closing a stake of 200 shares.

Householder Group Estate & Retirement Specialist first reported a position in CKPT in Q1 2023 and held it in 5 quarters. The position peaked at $1K in Q1 2023. 68 funds tracked by Wall St. Rank hold CKPT as of Q4 2024.

Householder Group Estate & Retirement Specialist reported no remaining Checkpoint Therapeutics position as of Q4 2024 after selling out during the quarter.
Householder Group Estate & Retirement Specialist sold 200 Checkpoint Therapeutics shares in Q4 2024.
Householder Group Estate & Retirement Specialist first reported a position in Checkpoint Therapeutics in Q1 2023 and held it in 5 quarters.
Householder Group Estate & Retirement Specialist's Checkpoint Therapeutics position peaked at $1K in Q1 2023.
68 funds tracked by Wall St. Rank held Checkpoint Therapeutics as of Q4 2024.

Based on Householder Group Estate & Retirement Specialist's 13F filing for Q4 2024, filed 15 Jan 2025.